🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

UPDATED: Red Line Delay: No longer single tracking. Residual delays continue in both directions following a person struck by a train at Friendship Heights.

Nice review in Current Problems in Cancer & CPC: Case Reports by Dr Jason Domogauer (he/him) on disparities in #cancerscreening for sexual and gender minorities #SGM and a review of organ-based routine cancer screenings recommended for #cisGender #transGender ♂️♀️⚧️ and non-binary folx. ➡️sciencedirect.com/science/articl…

Brian Van Tine Vivek Subbiah, MD Geraldine O'Sullivan Coyne Rafeh Naqash, MD Clinical Cancer Research There are many paired biopsies in this trial, thanks to our colleagues sarcoma research centers throughout the US, with pretreatment and on-treatment specimens being analyzed at #FrederickNationalLab. Have CTCs and blood as well. And, of course, follow-on trials…

Though not my area, would love the opportunity to work with Alexandra Zimmer again! #bcsm #breastcancer OHSU Knight Cancer Institute #MedOnc

Test your knowledge with our Case of the Week! NSCLC patient with NTRK fusion received entrectinib but developed CHF after 6 days requiring change in therapy that led to a partial response. #MedTwitter

Test your knowledge with our Case of the Week! What syndrome presents with renal neoplasms, fibrofolliculomas, and spontaneous pneumothoraces? #Medtwitter

Test your knowledge with our Case of the Week! History: Breast cancer patient undergoing neo-adjuvant chemotherapy presents with tongue changes. #MedTwitter #CPCcasereports Oncology Advance UPMC Hillman Cancer Center Adam Brufsky

The agent responsible is Doxorubicin. UPMC Hillman Cancer Center authors present a case of tongue hyperpigmentation that occurred during admin of doxorubicin & cyclophosphamide in the neoadjuvant setting for management of clinical stage IIIA breast cancer. (1/2) sciencedirect.com/science/articl…

Test your knowledge with our Case of the Week! History: Patient with CLL being treated on ibrutinib. #MedTwitter Oncology Advance (Case from C Jani, Z Pandit, H Singh, O Al Omari, T Caughey, D S Shapiro & P Lam - MountAuburnHospital, Harvard Medical School & Medical College of Wisconsin)

Great poster discussion session on Developmental Therapeutics - Immunotherapy chaired by Geraldine O'Sullivan Coyne Highlighting Abs2522 Mairi Lucas et al ☘️work on tumor microenvironment TILs, spatial phenotypes & tertiary lymphoid structures in HR+/HER2- breast ca #ASCO23 RCSI_StAR MD

Temporary Consultant Medical Oncologist post for suitably qualified applicants - now accepting applications! Royal College of Physicians of Ireland The BMJ Cancer | University of Galway-HSE West North West @saoltagroup @Saoltajobs saolta.ie/jobs/temporary…

We’re hiring! Come join us as we build this exciting venture Mater Hospital Advanced Cancer Care many opportunities: ADON/nurse lead, chief pharmacist, research nurse x2, patient navigator, data manager. Exciting times!

@"START Dublin Early Phase Clinical Trials Unit - Recruitment Now Open"linkedin.com/pulse/start-du… on LinkedIn

At University Hospital Galway @saoltagroup, a national The National Center for Children in Poverty designated and Organisation of European Cancer Institutes affiliated Cancer Centre, we have 2 posts open currently for Medical Oncology Registrars. We only appoint high quality candidates. To apply send your CV to [email protected]. 1/2

#ComboMATCH Treatment Trial E4, led by Dr. Alice Chen of @NCITreatment, is testing the use of therapy with nilotinib and paclitaxel for patients with #SolidTumors who previously had taxane therapy in the metastatic setting. Learn more: bit.ly/cmatch-e4 #PrecisionMedicine

Well done Tatiana Hernandez !!

Ok, lets try this again! Am leading the Guided Poster Walk #ASCO24 Trainee and Early Career Oncologist 🌠#DevelopmentalTherapeutics - Molecularly Targeted Agents and Tumor Biology 🕥10:30 - 11:30 AM CT 🗓️Saturday June 1 Lets go see and discuss some fab research!